ROLE OF SCLEROSING AGENT IN THE MANAGEMENT OF ORAL SOFT TISSUE GROWTHS- A CASE REPORT SERIES

Article Sidebar

Requires Subscription or Fee PDF (USD 30) PDF (INR 2100)
Published: Jul 6, 2021
   Page: 7-13

Main Article Content

PROMIT DEV SHARMA
Department of Internee, Burdwan Dental College & Hospital, Burdwan, India.
VINEET NAIR
Department of Periodontia, Burdwan Dental College & Hospital, Burdwan, India.
KRISHNA PADA DAS
Department of Dentistry, Calcutta National Medical College & Hospital, Kolkata, India.
NAIRITA SAHA
Burdwan Dental College & Hospital, Burdwan, India.

Abstract

Soft tissue enlargements of the oral cavity frequently present a diagnostic challenge because a varied group of pathologic processes can produce such lesions. Within these lesions is a group of reactive hyperplasias, which develop in response to a chronic, recurring tissue injury that stimulates an exuberant or excessive tissue repair response. Peripheral Giant Cell Granuloma (PGCG) is one of the most frequent giant cell lesions of the jaws. Treatment involves surgical resection with extensive clearing of the base of the lesion to avoid recurrence. However if the lesion is too big in size, then reduction in size of the lesion by sclerotherapy gives better results and reduces the chances of recurrence. This paper showcases some cases managed in this fashion.

Keywords:
Oral growth, peripheral giant cell granuloma, recurrence, sclerosing agent, sodium tetradecyl sulfate.

Article Details

How to Cite
SHARMA, P. D., NAIR, V., DAS, K. P., & SAHA, N. (2021). ROLE OF SCLEROSING AGENT IN THE MANAGEMENT OF ORAL SOFT TISSUE GROWTHS- A CASE REPORT SERIES. Journal of Case Reports in Medical Science, 7(2), 7-13. Retrieved from https://ikpresse.com/index.php/JOCRIMS/article/view/6638
Issue
2021 - Volume 7 [Issue 2]
Section
Case Report

References

Dhali S, Nair V, et al. Recurrence of oral pyogenic granuloma- a case series. Journal of Disease and Global Health. 2015;3(2):83-87.

Shadman N, Ebrahimi SE, Jafari S, Eslami Md. Peripheral giant cell granuloma: A review of 123 cases. Dent Res J. 2009;6:47-50.

Nair V, et al. Role of sodium tetradecyl sulfate in the management of an oral reactive hyperplastic lesion. Clinical Dentistry. 2015;5: 28-32.

Nair V, et al. Oral Pyogenic Granuloma in Pregnancy: A Predicament. International Medical Journal. 2016;23(1): 64-65.

Falaschini S, Ciavarella D, Mazzanti R, Di Cosola M, Turco M, Escudero N, et al. Peripheral giant cell granuloma: Immunohistochemical analysis of different markers. Study of three cases. Av. Odontoestomatol. 2007;23:189-196.

Motamedi MH, Eshghyar N, Jafari S.M, Lassemi E, Navi F, Abbas FM. Peripheral and central giant cell granulomas of the jaws: A demographic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:e39-e43.

Scurr JH. Venous disorders. In: Russell RC, Williams NS, Bulstrode CJ, editors. Bailey and Love's short practice of surgery. 24 th ed. London: Arnold Publishers. 2004; 956.

Morgan JF, Schow CE Jr. Use of sodium morrhuate in the management of hemangiomas. Oral Surg. 1974;32:363-366.

Riche MC, Hadjean E, Tran-Ba-Huy P, Merland JJ. The treatment of capillary- venous malformations using a new fibrosing agent. Plast Reconstr Surg. 1983; 71:607-614.

Cole PP, Hunt AH. The treatment of cavernous haemangiomas and cirsoid aneurysms by the injection of boiling water. Br J Surg. 1949;36:346.

Rotter SM, Weiss RA. Human saphenous vein in vitro model for studying the action of sclerosing solutions. J Dermatol Surg Oncol. 1993;19:59-62.

Lee CH, Chen SG. Direct percutaneous ethanol instillation for treatment of venous malformation in the face and neck. Br J Plast Surg. 2005;58:1073-1078.

Reiner L. The activity of anionic surface active compounds in producing vascular obliteration. Proc Soc Exp Biol Med. 1946;62:49-54.